ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Nurse Practitioner

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 411

$378K Total Retail Price of All Prescriptions

Rank: 56 out of 411

399 Patients Receiving at Least One Drug in Part D
62% Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in North Carolina
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

23% of this provider’s 399 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

14% of this provider’s 399 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 371 181 65 1 1
OXYCODONE HCL-ACETAMINOPHEN 255 48 56 S2 2 23
FUROSEMIDE 228 137 60 3 7
HYDROCODONE-ACETAMINOPHEN 200 112 49 S3 4 3
AMLODIPINE BESYLATE 198 147 36 5 4
ALPRAZOLAM 191 95 37 B 6 11
LISINOPRIL 190 126 43 7 2
ZOLPIDEM TARTRATE 189 92 34 8 18
POTASSIUM CHLORIDE 160 112 39 9 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 156 89 26 10 41
PRAVASTATIN SODIUM 143 99 35 11 14
SIMVASTATIN 131 92 32 12 6
GABAPENTIN 126 54 32 13 8
NEXIUM 116 38 23 14 26
METOPROLOL TARTRATE 110 84 23 15 13
OXYCODONE-ACETAMINOPHEN 100 26 30 S2 16 33
METOPROLOL SUCCINATE 98 44 17 17 15
PREDNISONE 97 45 51 18 29
METFORMIN HCL 96 54 20 19 10
ATORVASTATIN CALCIUM 92 56 17 20 9
AMOX TR-POTASSIUM CLAVULANATE 91 50 75 21 111
HYDROCHLOROTHIAZIDE 91 51 16 21 12
LEVOTHYROXINE SODIUM 87 23 16 23 5
LOSARTAN POTASSIUM 85 80* 15 24 28
DIAZEPAM 85 28 19 B 24 63
GLIMEPIRIDE 78 34 13 26 51
IBUPROFEN 77 11 18 27 120
CYCLOBENZAPRINE HCL 73 22 21 R 28 46
SERTRALINE HCL 72 47 11 29 31
FLUTICASONE PROPIONATE 71 41 40 30 30
CRESTOR 66 12 13 31 34
DIOVAN 66 <11 <11 31 69
OXYCODONE HCL 64 18 14 S2 33 16
CARVEDILOL 59 40 12 34 20
KLOR-CON M20 59 45 12 34 109
CLONAZEPAM 57 <11 <11 B 36 21
ADVAIR DISKUS 57 32 20 36 56
ATENOLOL 56 <11 <11 38 38
LEVOFLOXACIN 55 32 35 39 129
METFORMIN HCL ER 53 20 16 40 47
LORAZEPAM 52 14 15 B 41 19
CLOPIDOGREL 52 47* 13 41 22
PROAIR HFA 52 <11 22 41 35
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.